What We Do
We are developing a portfolio of products utilizing MARCKS technology for the treatment of Cancer and Acute Respiratory Distress Syndrome (ARDS).
bioMARCK is a biopharmaceutical company with a patented technology platform. We utilize anti-MARCKS peptides in order to develop and license products targeted at difficult to treat diseases with unmet needs. We are located in Research Triangle Park, N.C.